{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:27:06Z","timestamp":1787761626009,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"\n BACKGROUND:<\/jats:title>\n The angiotensin-converting enzyme 2 (ACE2) receptor, a membrane receptor present in the respiratory system, the gastrointestinal tracts, the heart, and the kidney is the entry point for SARS-CoV-2 to enter human cells. Concerns were raised about the influence of using antihypertensive drugs like angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in individuals with COVID-19 due to its tight relationship with the ACE2 receptor. The aim of this study was to investigate the impact of being on an Angiotensin Receptor Blockers (ARB) on mortality in patients consecutively diagnosed with COVID-19.<\/jats:p>\n <\/jats:sec>\n \n MATERIAL AND METHODS:<\/jats:title>\n This is the retrospective observational study done in all patients consecutively diagnosed with COVID-19 from January 2021 to June 2021. All related patient information and clinical data was retrieved from the hospitals electronic medical record system.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n \n In this study, out of 500 patients, 51 died, having mean age of 66.92 \u00b1 10.85 years. 144 (28.8%) patients were on angiotensin receptor blockers as antihypertensive treatment, 142 (28.4%) having other antihypertensive and 214 (42.8%) were not on any treatment. Out of 51 Death 7 (4.9) patients were on ARBs, 15 \u00b1 10.6 were on other medication [OR 2.31 (0.94\u20136.22,\n P<\/jats:italic>\n = 0.077) univariable; OR 2.57 (1.00\u20137.23,\n P<\/jats:italic>\n = 0.058) multivariable] and 29 \u00b1 13.6 had no treatment at all [OR 3.07 (1.38\u20137.80,\n P<\/jats:italic>\n = 0.010) univariable; OR 3.36 (1.41\u20139.08,\n P<\/jats:italic>\n = 0.010) multivariable].\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSION:<\/jats:title>\n Use of ARB medications for the hypertensive patients who acquire COVID-19 infection has shown protective effects of such medications on COVID-19 disease severity in the term of mortality and the mortality rate among hypertensive patients on COVID-19 with ARBs\/ACE inhibitors showed significant differences as compared to other antihypertensives.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/jehp.jehp_922_22","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T10:33:39Z","timestamp":1675074819000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Impact of angiotensin receptor blocker as antihypertensive in assessing mortality in patients of COVID-19: A single tertiary care center study"],"prefix":"10.4103","volume":"12","author":[{"given":"Sourya","family":"Acharya","sequence":"first","affiliation":[{"name":"Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchita","family":"Kabra","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Phate","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv","family":"Talwar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Daiya","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,1]]},"reference":[{"key":"R1-20240829","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7861\/clinmed.2019-coron","article-title":"What we know so far: COVID-19 current clinical knowledge and research","volume":"20","author":"Lake","year":"2020","journal-title":"Clin Med (Lond)"},{"key":"R2-20240829","article-title":"Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China","author":"Wu","year":"2020","journal-title":"bioRxiv"},{"key":"R3-20240829","article-title":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin","author":"Zhou","year":"2020","journal-title":"bioRxiv"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R7-20240829","first-page":"4","article-title":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)","volume":"7","author":"Jin","year":"2020","journal-title":"Mil Med Res"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/path.2987","article-title":"Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin-(1\u20137) or an angiotensin II receptor antagonist","volume":"225","author":"W\u00f6sten-van Asperen","year":"2011","journal-title":"J Pathol"},{"key":"R9-20240829","first-page":"e22528","article-title":"Role of zinc and clinicopathological factors for COVID-19-associated mucormycosis (CAM) in a rural hospital of central India: A case-control study","volume":"14","author":"Kumar","year":"2022","journal-title":"Cureus"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"R11-20240829","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/cid\/ciaa199","article-title":"Clinical characteristics of imported cases of COVID-19 in Jiangsu province: A multicenter descriptive study","volume":"71","author":"Wu","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"R12-20240829","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/joim.13202","article-title":"ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID-19","volume":"289","author":"Tetlow","year":"2021","journal-title":"J Intern Med"},{"key":"R13-20240829","first-page":"100660","article-title":"The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19","volume":"31","author":"Braude","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"R14-20240829","first-page":"21","article-title":"Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19","volume":"24","author":"Senkal","year":"2020","journal-title":"Anatol J Cardiol"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1161\/HYPERTENSIONAHA.120.15622","article-title":"Comparative impacts of ACE (Angiotensin-Converting Enzyme) inhibitors versus angiotensin ii receptor blockers on the risk of COVID-19 mortality","volume":"76","author":"Zhou","year":"2020","journal-title":"Hypertension"},{"key":"R16-20240829","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ejhf.1924","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust","volume":"22","author":"Bean","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"R17-20240829","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/heartjnl-2020-317336","article-title":"Treatment with ACE inhibitors or ARBs and risk of severe\/lethal COVID-19: A meta-analysis","volume":"106","author":"Flacco","year":"2020","journal-title":"Heart"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5005\/jp-journals-10071-24075","article-title":"Interleukin 6 and its correlation with COVID-19 in terms of outcomes in an intensive care unit of a rural hospital: A cross-sectional study","volume":"26","author":"Talwar","year":"2022","journal-title":"Indian J Crit Care Med"},{"key":"R19-20240829","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s11255-019-02235-w","article-title":"Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: The LAKESIDE trial","volume":"51","author":"Marashizadeh","year":"2019","journal-title":"Int Urol Nephrol"},{"issue":"16","key":"R20-20240829","article-title":"Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial","volume":"325","author":"Sadeghipour","year":"2021","journal-title":"JAMA"}],"container-title":["Journal of Education and Health Promotion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jehp.jehp_922_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:01:21Z","timestamp":1787760081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jehp.jehp_922_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jehp.jehp_922_22","relation":{},"ISSN":["2277-9531","2319-6440"],"issn-type":[{"value":"2277-9531","type":"print"},{"value":"2319-6440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2022-06-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}